SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients간경변 및 이식 환자에서 2차 예방접종 후 SARS-CoV 2 특이 체액 및 T 세포 면역 반응Article Published on 2022-01-012022-09-12 Journal: Clinical gastroenterology and hepatology : the off [Category] SARS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome age anti-S anti-SARS-CoV-2 anti-SARS-CoV-2 titer Arterial hypertension booster vaccinations cirrhosis Cohort Control controls coronavirus develop DiaSorin Effect Elecsy Euroimmun healthy control Heterologous humoral identify immune response immunoassay Immunosuppression immunosuppressive information inhibitor less LIAISON liver Liver cirrhosis liver transplant recipients Logistic regression analysis monotherapy Odds ratio Patient patient groups predictor prospective cohort study RBD recipient recipients reduction regimen Research response Roche routine SARS-CoV-2 SARS-CoV-2 vaccination second second vaccination Seroconversion Serological testing spike-protein spike-specific T-cell response T-cell T-cell Response Transplant trimer vaccination was performed [DOI] 10.1016/j.cgh.2021.09.003 PMC 바로가기 [Article Type] Article
Magnetofluidic immuno-PCR for point-of-care COVID-19 serological testing현장 진료 COVID-19 혈청 검사를 위한 자기유체 면역 PCRArticle Published on 2022-01-012022-09-11 Journal: Biosensors & bioelectronics [Category] SARS, 진단, 치료기술, [키워드] antibody Antibody detection cartridge chemiluminescence Community community infection Conventional coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 detect Device enzyme enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays evaluated immune response Immuno-PCR immunoassays Infection infection rate Laboratory lateral flow immunoassay Lateral flow immunoassays magnetic bead Magnetofluidic device plasma samples platform point-of-care point-of-care test reagent sensitivity serological test Serological testing Serological tests serum/plasma specificity the antibodies thermocycler Transport vaccination [DOI] 10.1016/j.bios.2021.113656 PMC 바로가기 [Article Type] Article
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities장기요양시설 입소자의 SARS-CoV-2-중화항체 동역학Article Published on 2022-01-012022-09-12 Journal: The journal of nutrition, health & aging [Category] SARS, 진단, [키워드] affected Analysis Antibody titer appear BNT162b2 Care Cellular immune response COVID-19 elderly Epidemic evaluate facility Follow-up high risk Immunity immunosenescence Kinetics material median morbidity Mortality NAb titer NAbs neutralization test neutralizing antibody nine nursing homes outbreak participant Particle Patient patients Pfizer positive serology Quantitative remained resident retroviral S glycoprotein SARS-CoV-2 SARS-COV-2 infection Seroconversion serological Serological assay Serological testing seronegative shown significant difference statistically significant susceptible T cell the SARS-CoV-2 virus timepoint university vaccination Vaccination strategy Vaccine [DOI] 10.1007/s12603-021-1713-4 PMC 바로가기 [Article Type] Article
Modeling serological testing to inform relaxation of social distancing for COVID-19 controlCOVID-19 통제를 위한 사회적 거리의 완화를 알리는 혈청학적 테스트 모델링Article Published on 2021-12-032022-09-10 Journal: Nature Communications [Category] 변종, 진단, 치료기술, [키워드] antibody benefit COVID-19 COVID-19 pandemic death Diseases finding Human behaviour Intervention mathematical mathematical model modeling New York City public health Puget Sound risk Serological testing seropositive individual seropositive individuals social distancing social interaction South state subsequent Transmission Transmission model variants viral infection Washington widespread [DOI] 10.1038/s41467-021-26774-y PMC 바로가기 [Article Type] Article
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment활성 치료 중인 암 환자에서 SARS-CoV-2 mRNA BNT162b2 백신에 대한 불량한 혈청 전환 및 유해 사례의 예측인자Observational Study Published on 2021-12-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, SARS, 바이오마커, 임상, 진단, [키워드] 95% CI Active surveillance active treatment adverse effects adverse event adverse events Antibody Response Antibody responses Antibody responses to the BNT162b2 vaccine benefit BNT162b2 BNT162b2 vaccine Cancer Cancer biological treatment cancer chemotherapy Cancer hormone therapy Cancer immunotherapy cancer patient Cancer patients Cancer target therapy candidate Chemotherapy ClinicalTrials conducted controls COVID-19 vaccine COVID-19 vaccine in cancer patients dose enrolled Factor female greater Hormone therapy IgG IgG response immunisation immunogenicity increasing age lack lymphocyte Lymphocyte count medications Mild mRNA BNT162b2 vaccine non-responders occur of BNT162b2 Older age Patient patients Patients with cancer predict predicted primary endpoint Prospective Study recruited responders risk S1/S2 SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccine adverse effects. second dose Seroconversion Serological testing significantly subject targeted therapy Therapies therapy Treatment women younger patient younger patients younger subject younger subjects [DOI] 10.1016/j.ejca.2021.09.030 PMC 바로가기 [Article Type] Observational Study
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in EnglandObservational Study Published on 2021-12-012022-10-05 Journal: The Lancet. Healthy longevity [Category] SARS, 변종, 임상, 진단, [키워드] Alpha Antigen binding Care Concentration COVID-19 vaccination Cox proportional hazard diagnostic Effectiveness eight England FIVE Follow-up follow-up period groups had no individual infected individual infected individuals Kinetics Lateral flow device London national guidelines natural infection Neutralising activity neutralising antibody nose and throat occurred Older participant Poisson regression positive Positive test Primary infection Primary outcome prospective observational cohort protection Protective Public recruited Reinfection required risk RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RT-PCR SARS-CoV-2 spike Serological testing staff Surveillance susceptible individual sustained swab sample symptomatic individuals tested timepoint titre transmissible variants understanding variant variants of SARS-CoV-2 were assessed were used [DOI] 10.1016/S2666-7568(21)00253-1 PMC 바로가기 [Article Type] Observational Study
Point-of-Care Testing—The Key in the Battle against SARS-CoV-2 PandemicReview Published on 2021-11-272022-10-30 Journal: Micromachines [Category] COVID-19, [키워드] approach battle coronavirus disease COVID-19 COVID-19 diagnosis deleterious effect detection diagnostic diagnostics disease effort Epidemic infection control Isolation Last limitation pandemic Perspective POCT point of care point of care testing polymerase chain qRT-PCR Quantitative SARS-CoV-2 SARS-CoV-2 detection SARS-CoV-2 variants Serological testing Spread Testing time-consuming Treatment [DOI] 10.3390/mi12121464 PMC 바로가기 [Article Type] Review
The burden of SARS-CoV-2 among healthcare workers across 16 hospitals of Kashmir, India—A seroepidemiological study인도 카슈미르의 16 개 병원에 걸친 의료 종사자들 사이에서 SARS-COV-2의 부담-혈청 환자 연구Research Article Published on 2021-11-192022-09-10 Journal: PLoS ONE [Category] MERS, 진단, 치료법, [키워드] 95% CI affected antibody cross-sectional cross-sectional study detect healthcare healthcare worker Healthcare workers high risk hospital India Infection Kashmir limit MOST Nasopharyngeal swab nasopharyngeal swab test nine nucleocapsid protein participated reported SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 pandemic Serological testing seropositive Seropositivity Symptom tested Transmission was performed [DOI] 10.1371/journal.pone.0259893 PMC 바로가기 [Article Type] Research Article
Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection감염 후 13 개월 동안 SARS-COV-2- 특이 적 항체의 지속성Article Published on 2021-11-192022-09-01 Journal: Viruses [Category] MERS, SARS, 진단, 치료기술, [키워드] antibody Antibody Response Antibody responses Asymptomatic COVID-19 vaccines declined Dynamics exposure to First wave IgG IgG and IgM IgG ELISA IgG level IgG levels IgG/IgM dynamics IgM individual infected individual Infection investigated Lithuania longitudinal study majority Month outbreak pandemic Reinfection remained S protein SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2 S SARS-CoV-2 S protein SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody second wave serological monitoring serological test Serological testing seropositive individual seropositive individuals Seropositivity Severity of infection specific antibodies specific IgM virus-specific antibodies Virus-specific IgG worker [DOI] 10.3390/v13112313 PMC 바로가기 [Article Type] Article
Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISAArticle Published on 2021-11-112022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Abbott Abbott IgG antibody assay analysed Analysis antibody Architect Asymptomatic can be used Characteristics collected comparable Concordance conducted contribute cut-off threshold demonstrated Determination determine discrepant result elevated ELISA ELISA kit evaluated Evidence false-negative feasible HCW HCWs healthcare worker individual longitudinal Mild NHS non-hospitalised nucleocapsid platform producing provided response responses ROC Curve Roche Roche Elecsys SARS-CoV-2 antibody assay SARS-CoV-2 SARS-CoV-2 IgG sensitive sensitivity Serological testing serology serology analysis Seroprevalence Site spike TBS The Binding Site total antibody assay threshold were used [DOI] 10.3390/vaccines9111310 PMC 바로가기 [Article Type] Article